ReviewFrontiers in neuroscience2026
Cannabinoid efficacy for pain: dose, chronicity and route.
Kaylin J Ellioff, Madalyn Critz, Nephi Stella, Michael R Bruchas, Benjamin B Land
Abstract readReview
In one paragraphReview in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Kaylin J Ellioff *Department of Pharmacology, University of Washington, Seattle, WA, United States.
Madalyn Critz *Department of Pharmacology, University of Washington, Seattle, WA, United States.
Nephi StellaDepartment of Pharmacology, University of Washington, Seattle, WA, United States.
Michael R BruchasDepartment of Pharmacology, University of Washington, Seattle, WA, United States.
Benjamin B LandDepartment of Pharmacology, University of Washington, Seattle, WA, United States.
Funding
University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0MDISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER37DA033396 · NIDA · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2018 to 2026
$3.8MCannabidiol and terpenoid interactions in amygdalar regulation of pain statesR01AT011524 · NCCIH · UNIVERSITY OF WASHINGTON · PI Benjamin Land · 2022 to 2026
$2.1MOral THC consumption during adolescence and its impact on adult mouse brainR01DA061185 · NIDA · UNIVERSITY OF WASHINGTON · PI Benjamin Land, Nephi Stella · 2025 to 2026
$1.4MInvestigating the role of THC in mediating pain signaling in the BLAF31DA061576 · NIDA · UNIVERSITY OF WASHINGTON · PI Kaylin Ellioff · 2024 to 2026
$139kNCCIH NIH HHS R01 AT011524NIDA NIH HHS F31 DA061576NIDA NIH HHS P30 DA048736NIDA NIH HHS R01 DA061185NIDA NIH HHS R37 DA033396
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
behaviorcannabidiolDelta-9-tetrahydrocannabinolentouragemachine-learningpainterpene
Identifiers
PMID42661783
PMCPMC13518349
What OpenQuestion holds
Textmetadata
Read underepoch 390